glp 1 post partum GLP-1 agonists are showing up more often in our pelvic health caseloads — pre-conception, postpartum, and across the lifespan. What we do know: • Higher BMI is a risk factor for pelvic Contributor: New mothers are tempted

It is worth noting that GLP-1 receptor agonists show neutral effects on heart failure hospitalisation, unlike SGLT2 inhibitors which demonstrate benefit in this area

Although GLP-1 receptor agonists are mostly intended to be diabetes drugs, they are now being used not just for managing blood sugar but also for treating obesity and aiding in long-term weight management

The body's adaptation to significant caloric restriction and metabolic changes during weight loss can also contribute to feelings of tiredness

Not all online providers are equal

A qualified healthcare provider should evaluate whether GLP-1 treatment is appropriate for any individual under 30 years old, weighing comorbidities, weight loss goals, diabetes status, and long-term safety data gaps

and C.J.H